No Detail Found!

Sunitinib-induced hand-foot syndrome in a Kashmiri male.

Author(s)
Mohammad H Mir Department of Medical Oncology, Sheri Kashmir Institute of Medical Sciences, Srinagar, J & K, India
Parvaiz A Rather Department of Dermatology, STD & Leprosy, Govt. Medical College, Srinagar, J & K, India
Farhana Bagdadi Department of Internal Medicine, Sheri Kashmir Institute of Medical Sciences, Srinagar, J & K, India
Abstract
Sunitinib belongs to multiple tyrosine kinase inhibitor class of novel targeted therapies used for metastatic solid tumours including renal cell carcinoma. A variety of systemic, as well as, cutaneous side effects due to sunitinib have been described including the hand foot syndrome. We report sunitinib-induced hand foot syndrome in a 65-year-old Kashmiri male and review the literature.
Publication Details
Page(s) 180-182
DOI DOI not available
Published Journal: Journal of Pakistan Association of Dermatologists, Volume: 24, Issue: 2, Year: 2014

Request the full text from PASTIC

0

Citations

0

Downloads

50

Views